Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/PEP.0000000000000725 | DOI Listing |
Ann Behav Med
December 2024
Department of Psychology, University of California, Los Angeles, Los Angeles, CA 90095, United States.
Glucagon-like peptide-1 (GLP-1) agonist medications are receiving high levels of attention because of their dramatic efficacy in causing weight loss. This commentary discusses several ways that those in behavioral medicine and health psychology might think about these medications-whether they should be fully in support of them or whether they pose a risk. The positive aspects of GLP-1s include their great promise in improving health independent of weight loss and the perspective that their efficacy frees individuals from the difficulties of behavioral weight maintenance and the associated stigma of "failing" to lose weight.
View Article and Find Full Text PDFJ Neurophysiol
December 2024
Jefferson Moss Rehabilitation Research Institute, Thomas Jefferson University, Elkins Park, Pennsylvania, United States.
J Assoc Nurses AIDS Care
November 2024
Duke University School of Nursing and a Professor of Nursing and Global Health, Duke University, Durham, North Carolina, USA.
There is a shortage of health-related questionnaires developed specifically for African countries' cultural contexts and local languages. Researchers have translated some tools to the target local languages. However, poor quality translation, or even high-quality translation, can lead to an instrument that is not comparable to the original language if linguistic nuances and cultural differences are not considered.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!